Melanocortins and body weight regulation: Glucocorticoids, Agouti-related protein and beyond

European Journal of Pharmacology

Volumn 660, Issue 1, 2011, Pages 111-118

  Corander, Marcus P ^a   Coll, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adrenal; Corticosterone; Energy homeostasis; Melanocortin; Obesity; POMC

Indexed keywords

AGOUTI RELATED PROTEIN; CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN;

ADRENAL GLAND; BODY WEIGHT; FEEDING BEHAVIOR; FOOD INTAKE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOSITY; HOMOZYGOSITY; MITOGENICITY; MOLECULAR BIOLOGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

AGOUTI-RELATED PROTEIN; ANIMALS; BODY WEIGHT; DIETARY FATS; GLUCOCORTICOIDS; HUMANS; MELANOCORTINS; PHENOTYPE;

EID: 79955931571     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.103     Document Type: Review

References (77)

1. Abayasekara, D.R., Vazir, H., Whitehouse, B.J., Price, G.M., Hinson, J.P., Vinson, G.P., 1989. Studies on the mechanisms of ACTH-induced inhibition of aldosterone biosynthesis in the rat adrenal cortex. J. Endocrinol. 122, 625-632. (Pubitemid 19220617)
2. Adan, R.A., 2006. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system. Trends Pharmacol. Sci. 27, 183-186.
3. Barsh, G.S., Ollmann, M.M., Wilson, B.D., Miller, K.A., Gunn, T.M., 1999. Molecular pharmacology of Agouti protein in vitro and in vivo. Ann. NY Acad. Sci. 885, 143-152.
4. Beuschlein, F., Mutch, C., Bavers, D.L., Ulrich-Lai, Y.M., Engeland, W.C., Keegan, C., Hammer, G.D., 2002. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 143, 3122-3135. (Pubitemid 34809885)
5. Bewick, G.A., Gardiner, J.V., Dhillo, W.S., Kent, A.S., White, N.E., Webster, Z., Ghatei, M.A., Bloom, S.R., 2005. Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J. 19, 1680-1682. (Pubitemid 41429528)
6. Bicknell, A.B., 2002. Identification of a receptor for N-POMC peptides. Endocr. Res. 28, 309-314.
7. Bicknell, A.B., Lomthaisong, K., Woods, R.J., Hutchinson, E.G., Bennett, H.P., Gladwell, R.T., Lowry, P.J., 2001. Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell 105, 903-912. (Pubitemid 32635091)
8. Biebermann, H., Castaneda, T.R., van Landeghem, F., von Deimling, A., Escher, F., Brabant, G., Hebebrand, J., Hinney, A., Tschop, M.H., Gruters, A., Krude, H., 2006. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 3, 141-146.
9. Broberger, C., Hokfelt, T., 2001. Hypothalamic and vagal neuropeptide circuitries regulating food intake. Physiol. Behav. 74, 669-682.
10. Challis, B.G., Coll, A.P., Yeo, G.S., Pinnock, S.B., Dickson, S.L., Thresher, R.R., Dixon, J., Zahn, D., Rochford, J.J., White, A., Oliver, R.L., Millington, G., Aparicio, S.A., Colledge, W.H., Russ, A.P., Carlton, M.B., O'Rahilly, S., 2004. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc. Natl Acad. Sci. USA 101, 4695-4700.
11. Chen, M., Celik, A., Georgeson, K.E., Harmon, C.M., Yang, Y., 2006. Molecular basis of melanocortin-4 receptor for AGRP inverse agonism. Regul. Pept. 136, 40-49.
12. Chida, D., Nakagawa, S., Nagai, S., Sagara, H., Katsumata, H., Imaki, T., Suzuki, H., Mitani, F., Ogishima, T., Shimizu, C., Kotaki, H., Kakuta, S., Sudo, K., Koike, T., Kubo, M., Iwakura, Y., 2007. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc. Natl Acad. Sci. USA 104, 18205-18210.
13. Clark, A.J., Weber, A., 1998. Adrenocorticotropin insensitivity syndromes. Endocr. Rev. 19, 828-843.
14. Coll, A.P., Challis, B.G., Lopez, M., Piper, S., Yeo, G.S., O'Rahilly, S., 2005. Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids. Diabetes 54, 2269-2276. (Pubitemid 41134252)
15. Coll, A.P., Challis, B.G., Yeo, G.S., Snell, K., Piper, S.J., Halsall, D., Thresher, R.R., O'Rahilly, S., 2004. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145, 4721-4727. (Pubitemid 39281466)
16. -/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. J. Endocrinol. 190, 515-525.
17. Comuzzie, A.G., Hixson, J.E., Almasy, L., Mitchell, B.D., Mahaney, M.C., Dyer, T.D., Stern, M.P., MacCluer, J.W., Blangero, J., 1997. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat. Genet. 15, 273-276.
18. Cone, R.D., 1999. The central melanocortin system and energy homeostasis. Trends Endocrinol. Metab. 10, 211-216.
19. Cowley, M.A., Smart, J.L., Rubinstein, M., Cerdan, M.G., Diano, S., Horvath, T.L., Cone, R.D., Low, M.J., 2001. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484. (Pubitemid 32494394)
20. Creemers, J.W., Pritchard, L.E., Gyte, A., Le Rouzic, P., Meulemans, S., Wardlaw, S.L., Zhu, X., Steiner, D.F., Davies, N., Armstrong, D., Lawrence, C.B., Luckman, S.M., Schmitz, C.A., Davies, R.A., Brennand, J.C., White, A., 2006. Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate Agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3. Endocrinology 147, 1621-1631.
21. Ebihara, K., Ogawa, Y., Katsuura, G., Numata, Y., Masuzaki, H., Satoh, N., Tamaki, M., Yoshioka, T., Hayase, M., Matsuoka, N., Aizawa-Abe, M., Yoshimasa, Y., Nakao, K., 1999. Involvement of Agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes 48, 2028-2033. (Pubitemid 29458367)
22. Elias, C.F., Aschkenasi, C., Lee, C., Kelly, J., Ahima, R.S., Bjorbaek, C., Flier, J.S., Saper, C.B., Elmquist, J.K., 1999. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23, 775-786. (Pubitemid 29411566)
23. Estivariz, F.E., Carino, M., Lowry, P.J., Jackson, S., 1988a. Further evidence that N-terminal pro-opiomelanocortin peptides are involved in adrenal mitogenesis. J. Endocrinol. 116, 201-206. (Pubitemid 18033284)
24. Estivariz, F.E., Iturriza, F., McLean, C., Hope, J., Lowry, P.J., 1982. Stimulation of adrenal mitogenesis by N-terminal proopiocortin peptides. Nature 297, 419-422. (Pubitemid 12025095)
25. Estivariz, F.E., Morano, M.I., Carino, M., Jackson, S., Lowry, P.J., 1988b. Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary. J. Endocrinol. 116, 207-216.
26. Fan, W., Ellacott, K.L., Halatchev, I.G., Takahashi, K., Yu, P., Cone, R.D., 2004. Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system. Nat. Neurosci. 7, 335-336.
27. Farooqi, I.S., Drop, S., Clements, A., Keogh, J.M., Biernacka, J., Lowenbein, S., Challis, B.G., O'Rahilly, S., 2006. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 55, 2549-2553. (Pubitemid 44871155)
28. Fassnacht, M., Hahner, S., Hansen, I.A., Kreutzberger, T., Zink, M., Adermann, K., Jakob, F., Troppmair, J., Allolio, B., 2003a. N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis. J. Clin. Endocrinol. Metab. 88, 2171-2179.
29. Fassnacht, M., Hahner, S., Hansen, I.A., Kreutzberger, T., Zink, M., Adermann, K., Jakob, F., Troppmair, J., Allolio, B., 2003b. N-terminal Proopiomelanocortin acts as a mitogen in adsrenocortical tumor cells and decreases adrenal steroidogenesis. J. Clin. Endocrinol. Metab. 88, 2171-2179.
30. Fekete, C., Marks, D.L., Sarkar, S., Emerson, C.H., Rand, W.M., Cone, R.D., Lechan, R.M., 2004. Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse. Endocrinology 145, 4816-4821. (Pubitemid 39551096)
31. Graham, M., Shutter, J.R., Sarmiento, U., Sarosi, I., Stark, K.L., 1997. Overexpression of Agrt leads to obesity in transgenic mice. Nat. Genet. 17, 273-274.
32. Gropp, E., Shanabrough, M., Borok, E., Xu, A.W., Janoschek, R., Buch, T., Plum, L., Balthasar, N., Hampel, B., Waisman, A., Barsh, G.S., Horvath, T.L., Bruning, J.C., 2005. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8, 1289-1291.
33. Hagan, M.M., Rushing, P.A., Benoit, S.C., Woods, S.C., Seeley, R.J., 2001. Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R814-R821.
34. Hagan, M.M., Rushing, P.A., Pritchard, L.M., Schwartz, M.W., Strack, A.M., Van Der Ploeg, L.H., Woods, S.C., Seeley, R.J., 2000. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R47-R52.
35. Hahner, S., Fassnacht, M., Hammer, F., Schammann, M., Weismann, D., Hansen, I.A., Allolio, B., 2005. Evidence against a role of human airway trypsin-like protease-the human analogue of the growth-promoting rat adrenal secretory protease-in adrenal tumourigenesis. Eur. J. Endocrinol. 152, 143-153.
36. Hansen, I.A., Fassnacht, M., Hahner, S., Hammer, F., Schammann, M., Meyer, S.R., Bicknell, A.B., Allolio, B., 2004. The adrenal secretory serine protease AsP is a short secretory isoform of the transmembrane airway trypsin-like protease. Endocrinology 145, 1898-1905. (Pubitemid 38402399)
37. Haskell-Luevano, C., Monck, E.K., 2001. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept. 99, 1-7.
38. Huo, L., Grill, H.J., Bjorbaek, C., 2006. Divergent regulation of proopiomelanocortin neurons by leptin in the nucleus of the solitary tract and in the arcuate hypothalamic nucleus. Diabetes 55, 567-573. (Pubitemid 43343211)
39. Karpac, J., Ostwald, D., Bui, S., Hunnewell, P., Shankar, M., Hochgeschwender, U., 2005. Development, maintenance, and function of the adrenal gland in early postnatal proopiomelanocortin-null mutant mice. Endocrinology 146, 2555-2562. (Pubitemid 40695558)
40. Kim, D.H., Shin, S.W., Baik, J.H., 2008. Role of third intracellular loop of themelanocortin 4 receptor in the regulation of constitutive activity. Biochem. Biophys. Res. Commun. 365, 439-445.
41. Koegler, F.H., Schaffhauser, R.O., Mynatt, R.L., York, D.A., Bray, G.A., 1999. Macronutrient diet intake of the lethal yellow Agouti (Ay/a) mouse. Physiol. Behav. 67, 809-812.
42. Krude, H., Biebermann, H., Schnabel, D., Tansek, M.Z., Theunissen, P., Mullis, P.E., Gruters, A., 2003. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J. Clin. Endocrinol. Metab. 88, 4633-4640.
43. Krude, H., Gruters, A., 2000. Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol. Metab. 11, 15-22.
44. Lee, Y.S., Challis, B.G., Thompson, D.A., Yeo, G.S., Keogh, J.M., Madonna, M.E., Wraight, V., Sims, M., Vatin, V., Meyre, D., Shield, J., Burren, C., Ibrahim, Z., Cheetham, T., Swift, P., Blackwood, A., Hung, C.C., Wareham, N.J., Froguel, P., Millhauser, G.L., O'Rahilly, S., Farooqi, I.S., 2006. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 3, 135-140.
45. Lowry, P.J., Silas, L., McLean, C., Linton, E.A., Estivariz, F.E., 1983. Pro-gamma-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature 306, 70-73. (Pubitemid 13022770)
46. Luquet, S., Perez, F.A., Hnasko, T.S., Palmiter, R.D., 2005. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310, 683-685. (Pubitemid 41528162)
47. Marsh, D.J., Miura, G.I., Yagaloff, K.A., Schwartz, M.W., Barsh, G.S., Palmiter, R.D., 1999. Effects of neuropeptide Y deficiency on hypothalamic Agouti-related protein expression and responsiveness to melanocortin analogues. Brain Res. 848, 66-77. (Pubitemid 30001655)
48. McLean, C., Hope, J., Salacinski, P., Estivariz, F., Lowry, P.J., 1981. Purification and characterization of amino-terminal pro-opiocortin peptides from human pituitary glands. Biosci. Rep. 1, 843-849.
49. Michailidou, Z., Coll, A.P., Kenyon, C.J., Morton, N.M., O'Rahilly, S., Seckl, J.R., Chapman, K.E., 2007. Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone. J. Endocrinol. 194, 161-170. (Pubitemid 47177107)
50. Mizuno, T.M., Kleopoulos, S.P., Bergen, H.T., Roberts, J.L., Priest, C.A., Mobbs, C.V., 1998. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47, 294-297. (Pubitemid 28079992)
51. Mizuno, T.M., Makimura, H., Silverstein, J., Roberts, J.L., Lopingco, T., Mobbs, C.V., 1999. Fasting regulates hypothalamic neuropeptide Y, Agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Endocrinology 140, 4551-4557. (Pubitemid 30666120)
52. Mizuno, T.M., Mobbs, C.V., 1999. Hypothalamic Agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140, 814-817. (Pubitemid 29058217)
53. Muller, J., 1978. Suppression of aldosterone biosynthesis by treatment of rats with adrenocorticotropin: comparison with glucocorticoid effects. Endocrinology 103, 2061-2068.
54. Nijenhuis, W.A., Oosterom, J., Adan, R.A., 2001. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15, 164-171.
55. Ollmann, M.M., Wilson, B.D., Yang, Y.K., Kerns, J.A., Chen, Y., Gantz, I., Barsh, G.S., 1997. Antagonism of central melanocortin receptors in vitro and in vivo by Agouti-related protein. Science 278, 135-138. (Pubitemid 27446294)
56. Panksepp, J., Meeker, R., 1976. Suppression of food intake in diabetic rats by voluntary consumption and intrahypothalamic injection of glucose. Physiol. Behav. 16, 763-770.
57. Qian, S., Chen, H., Weingarth, D., Trumbauer, M.E., Novi, D.E., Guan, X., Yu, H., Shen, Z., Feng, Y., Frazier, E., Chen, A., Camacho, R.E., Shearman, L.P., Gopal-Truter, S., MacNeil, D.J., Van der Ploeg, L.H., Marsh, D.J., 2002. Neither Agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell. Biol. 22, 5027-5035.
58. Rebuffat, P., Neri, G., Andreis, P.G., Belloni, A.S., Mazzocchi, G., Musajo, F.G., Nussdorfer, G.G., 1991. Effects of prolonged treatment with adrenocorticotropin on the morphology and function of rat adrenocortical autotransplants. Cytobios 65, 101-113.
59. Rossi, M., Kim, M.S., Morgan, D.G., Small, C.J., Edwards, C.M., Sunter, D., Abusnana, S., Goldstone, A.P., Russell, S.H., Stanley, S.A., Smith, D.M., Yagaloff, K., Ghatei, M.A., Bloom, S.R., 1998. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139, 4428-4431. (Pubitemid 28513735)
60. Samama, P., Rumennik, L., Grippo, J.F., 2003. The melanocortin receptor MCR4 controls fat consumption. Regul. Pept. 113, 85-88.
61. Schwartz, G.J., 2000. The role of gastrointestinal vagal afferents in the control of food intake: current prospects. Nutrition 16, 866-873.
62. Schwartz, M.W., Woods, S.C., Porte Jr., D., Seeley, R.J., Baskin, D.G., 2000. Central nervous system control of food intake. Nature 404, 661-671. (Pubitemid 30205071)
63. Shutter, J.R., Graham, M., Kinsey, A.C., Scully, S., Luthy, R., Stark, K.L., 1997. Hypothalamic expression of ART, a novel gene related to Agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11, 593-602. (Pubitemid 27133379)
64. Smart, J.L., Low, M.J., 2003. Lack of proopiomelanocortin peptides results in obesity and defective adrenal function but normal melanocyte pigmentation in the murine C57BL/6 genetic background. Ann. NY Acad. Sci. 994, 202-210.
65. Smart, J.L., Tolle, V., Low, M.J., 2006. Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice. J. Clin. Invest. 116, 495-505.
66. Srinivasan, S., Lubrano-Berthelier, C., Govaerts, C., Picard, F., Santiago, P., Conklin, B.R., Vaisse, C., 2004. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J. Clin. Invest. 114, 1158-1164.
67. Tolle, V., Low, M.J., 2008. In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin- deficient mice. Diabetes 57, 86-94.
68. Torres, T.E., de Mendonca, P.O., Lotfi, C.F., 2010. Synthetic modified N-POMC(1-28) controls in vivo proliferation and blocks apoptosis inrat adrenal cortex. Cell Tissue Res. 341 (2), 239-250.
69. Tung, Y.C., Piper, S.J., Yeung, D., O'Rahilly, S., Coll, A.P., 2006. A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice. Endocrinology 147, 5940-5947. (Pubitemid 44833512)
70. Tung, Y.C., Rimmington, D., O'Rahilly, S., Coll, A.P., 2007. Pro-opiomelanocortin modulates the thermogenic and physical activity responses to high-fat feeding and markedly influences dietary fat preference. Endocrinology 148, 5331-5338. (Pubitemid 350012625)
71. Vallette-Kasic, S., Pulichino, A.M., Gueydan, M., Barlier, A., David, M., Malpuech, G., Deal, C., VanVliet, G., de Vroede, M., Riepe, F., Partsch, C.J., Sippell, W., Berberoglu, M., Atasay, B., de Zegher, F., Kyllo, J., Donohoue, P., Dechelotte, P., Fassnacht, M., Noordam, K., Dunkel, L., Pigeon, B., Weill, J., Yigit, S., Brauner, R., Leger, J., Heinrich, J.J., Enjalbert, A., Brue, T., Drouin, J., 2004. A neonatal form of isolated ACTH deficiency frequently associated with Tpit gene mutations. Endocr. Res. 30, 943-944.
72. Wolff, G.L., Roberts, D.W., Mountjoy, K.G., 1999. Physiological consequences of ectopic Agouti gene expression: the yellow obese mouse syndrome. Physiol. Genomics 1, 151-163. (Pubitemid 129622462)
73. Wortley, K.E., Anderson, K.D., Yasenchak, J., Murphy, A., Valenzuela, D., Diano, S., Yancopoulos, G.D., Wiegand, S.J., Sleeman, M.W., 2005. Agouti-related protein-deficient mice display an age-related lean phenotype. Cell Metab. 2, 421-427.
74. Wu, Q., Boyle, M.P., Palmiter, R.D., 2009. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell 137, 1225-1234.
75. Wu, Q., Howell, M.P., Cowley, M.A., Palmiter, R.D., 2008. Starvation after AgRP neuron ablation is independent of melanocortin signaling. Proc. Natl Acad. Sci. USA 105, 2687-2692.
76. Xu, A.W., Kaelin, C.B., Morton, G.J., Ogimoto, K., Stanhope, K., Graham, J., Baskin, D.G., Havel, P., Schwartz, M.W., Barsh, G.S., 2005. Effects of hypothalamic neurodegeneration on energy balance. PLoS Biol. 3, e415.
77. Yaswen, L., Diehl, N., Brennan, M.B., Hochgeschwender, U., 1999. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 5, 1066-1070.